ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

2019 ACR/ARP Annual Meeting

November 8-13, 2019. Atlanta, GA.

View by Number View by Title View Sessions
View by Date

Monday, November 11, 2019

9:00AM-11:00AM
Abstract Number: 1157
#WomeninRheumatology: Is There a Speaker Gender Gap at ACR Meetings?
Healthcare Disparities In Rheumatology Poster
9:00AM-11:00AM
Abstract Number: 1071
A Common Transcriptional Signature Is Present in Circulating Classical Monocytes and Skin Macrophages in Systemic Sclerosis
Systemic Sclerosis & Related Disorders – Basic Science Poster
9:00AM-11:00AM
Abstract Number: 1355
A Comparison of Clinical Improvement Following a Major Therapeutic Change Utilizing Updated Treatment Thresholds Defined by Three Different Disease Activity Measures
RA – Diagnosis, Manifestations, & Outcomes Poster II: Treatments, Outcomes, & Measures
9:00AM-11:00AM
Abstract Number: 1354
A Comparison of Convergent Validity and Sensitivity to Change of the Conventional Scoring Method to Alternative Scoring Methods of the Health Assessment Questionnaire in Rheumatoid Arthritis
RA – Diagnosis, Manifestations, & Outcomes Poster II: Treatments, Outcomes, & Measures
9:00AM-11:00AM
Abstract Number: 1126
A Medical Assistant Driven Quality Improvement Intervention Increases Rates of DEXA Screening Among RA Patients
Health Services Research Poster II – ACR/ARP
9:00AM-11:00AM
Abstract Number: 1215
A Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-Ranging Study to Evaluate Efficacy and Tolerability of SHR4640 in Patients with Hyperuricemia
Metabolic & Crystal Arthropathies Poster II: Clinical Trials & Basic Science
9:00AM-11:00AM
Abstract Number: 1227
A Neutrophil Signature Is Strongly Associated with Cardiovascular Risk in Gout
Metabolic & Crystal Arthropathies Poster II: Clinical Trials & Basic Science
9:00AM-11:00AM
Abstract Number: 1166
A New Risk Factor for Predicting the Long-term Outcome of Pulmonary Arterial Hypertension Associated with Connective Tissue Disease: Pulmonary Artery Size Measured by Chest Computed Tomography
Imaging Of Rheumatic Diseases Poster II
9:00AM-11:00AM
Abstract Number: 959
A Novel Image Analysis Program, “CytoSkaler”, Demonstrates That Anti-Vimentin Antibody Affinity Maturation in Lupus Tubulointerstitial Nephritis Also Results in More Selective Antigen Targeting
B Cell Biology & Targets In Autoimmune & Inflammatory Disease Poster
9:00AM-11:00AM
Abstract Number: 1536
A Novel MK2 Inhibitor for the Treatment of Ankylosing Spondylitis and Other Inflammatory Diseases
Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster II: Treatment of Axial Spondyloarthritis & Psoriatic Arthritis
9:00AM-11:00AM
Abstract Number: 982
A Novel Role for Nod2 in Controlling Autoantibody Production and Arthritis in SKG Mice
RA – Animal Models Poster
9:00AM-11:00AM
Abstract Number: 1307
A Prospective, Multi-center, Randomized, Clinical Trial Comparing the Effectiveness and Safety of Cooled Radiofrequency Ablation versus a Single Injection of Hyaluronic Acid in the Management of OA Knee Pain
Osteoarthritis – Clinical Poster I
9:00AM-11:00AM
Abstract Number: 1207
A Quality Improvement Intervention to Reduce 30-Day Hospital Readmission Rates Among Patients with Systemic Lupus Erythematosus
Measures Of Healthcare Quality Poster II: Improving Care
9:00AM-11:00AM
Abstract Number: 1190
A Quality Improvement Project to Increase Documentation Efficiency in an Academic Rheumatology Practice
Measures Of Healthcare Quality Poster II: Improving Care
9:00AM-11:00AM
Abstract Number: 1298
A Randomised Clinical Trial of Curcuma Longa Extract for Treating Symptoms and Effusion-Synovitis of Knee Osteoarthritis
Osteoarthritis – Clinical Poster I
  • 1
  • 2
  • 3
  • …
  • 65
  • Next Page»
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology